Linezolid-induced thrombocytopenia in patients with acute myeloid leukemia: a matched case–control study
Sign Up to like & getrecommendations! Published in 2021 at "Clinical and Translational Oncology"
DOI: 10.1007/s12094-021-02711-9
Abstract: After the wide use of linezolid (LZD), numerous reports of uncontrolled studies have suggested that LZD is associated with high rates of thrombocytopenia. We conducted this matched case–control study to identify the risk factors for… read more here.
Keywords: control study; thrombocytopenia patients; study; induced thrombocytopenia ... See more keywords
Avatrombopag for the treatment of thrombocytopenia in patients with chronic liver disease
Sign Up to like & getrecommendations! Published in 2019 at "Expert Review of Clinical Pharmacology"
DOI: 10.1080/17512433.2019.1649137
Abstract: ABSTRACT Introduction: Thrombocytopenia is a common hematological abnormality in patients with chronic liver disease (CLD), occurring in 64%~84% of patients with cirrhosis or fibrosis. Due to the increased risk of bleeding, thrombocytopenia potentially affects management… read more here.
Keywords: thrombocytopenia; thrombocytopenia patients; avatrombopag; patients chronic ... See more keywords
Treatment of essential thrombocytopenia patients intolerant/ resistant to hydroxyurea: A physician survey.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2017.35.15_suppl.e18565
Abstract: e18565Introduction: Hydroxyurea (HU) is deemed first-line cytoreductive therapy for patients with essential thrombocythemia (ET) at high-risk for vascular complications with 20-25% of patients deve... read more here.
Keywords: intolerant resistant; essential thrombocytopenia; thrombocytopenia patients; hydroxyurea ... See more keywords